Tilray EMEA

Tilray EMEA is owned by Tilray. Tilray has a direct presence in 2 countries.

They are in:

• Household Products50%
• Pharmaceuticals50%

Acquisition, funding and merger involving Tilray.

• Tilray has just announced a $150 Million fundraising (posted on May 31 2023).

View the org chart displaying its 6 main executives

Most searched biographies at Tilray EMEA

• Sascha Mielcarek, Managing Director
• Dounia Farajallah, Country Manager, France
• Natalie Bucceri, Vice President, Strategy and Business Development

Create your alert
to follow the executive moves at Tilray EMEA.

Tilray has 1,838 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• ANI Pharmaceuticals has announced the acquisition of Alimera Sciences  (posted on June 26 2024).
• Sun Pharma has acquired Taro Pharmaceutical (posted on June 25 2024).
• ONO Pharmaceutical has acquired Deciphera Pharmaceuticals (posted on June 12 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Anat Ashkenazi - Senior Vice President and Chief Financial Officer (until Jul 31 2024) at Eli Lilly
• Danilo Cicmil - Supervisory Board Member at Galenika

Learn more about the Pharmaceuticals industry >

Press releases by Tilray EMEA

Social media about Tilray EMEA

• Tilray EMEA on Wikipedia, Google News & Yahoo Finance
• Tilray EMEA on LinkedIn, Twitter & YouTube

Contact by email its executives including Sascha Mielcarek

Call Tilray EMEA at +49 800...

View the org chart

Register to receive your alert

Report an error